Android Apple

Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development

By Yahoo! Finance   |   6 months ago
Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development

Fady Malik, Executive VP at Cytokinetics Inc, sold 7,788 shares on June 11, 2024, bringing his total to 135,004 shares. The company focuses on developing muscle function modulating therapeutics.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.